Amyris Gives Up Making Biofuels
http://www.technologyreview.com/blog/energy/27570/?p1=blogs
An Amyris demonstration facility in Brazil. Credit: Noah Friedman-Rudovsky
In its early years, biotech company Amyris described itself as a start-up applying its proprietary breakthrough technologies to address major global health and energy challenges.
Its originally planned to make an anti-malaria drug, as well as renewable diesel and jet fuel, by feeding sugar to genetically-engineered microorganisms. Having spun off the anti-malaria technology to another company in 2008, yesterday Amyris said its giving up making fuels too. Instead, it will to focus on higher value products, such as moisturizers for cosmetics.
The company learnt first hand just how difficult it is to achieve the kind of yields seen in lab tests in large-scale production. In an update call for investors, CEO John Melo said he is humbled by the lessons we have learned.
This is a common theme for advanced biofuels companies. Range Fuels, one of the first of the current crop of companies, recently went out of business. Others are giving up on making biofuels too, also hoping to break into markets for higher value chemicals. Although they may be able to get more money per liter of product, some experts warn that these markets are also highly competitive.
Amyriss technology may still be used to make renewable fuels, but this will happen not at Amyris, but under joint ventures established with Total and Cosan. These ventures will need to build up their own production capacity, Melo told analysts.